Terminal Malignant Disease Research Articles

Quality of Life —a Review of the Literature

This review of the literature looks at the meaning of the concept 'quality of life', the use to which it has been put in various branches of medicine, its meaning in particular in cancer patients, especially those for whom there is no longer expectation of cure, and the instruments already developed for its measurement and their relevance to terminal care. The review concentrates mainly on patients with terminal malignant disease as the quality of life of other patients is a much broader issue.

BOOK REVIEWS

Journal Article BOOK REVIEWS Get access The Management of Terminal Malignant Disease. Edited by Dame Cicely Saunders. London: Edward Arnold. Second edition. 1984. 252 pp. Price £22.50. T. N. RUDD T. N. RUDD Search for other works by this author on: Oxford Academic PubMed Google Scholar Age and Ageing, Volume 14, Issue 5, September 1985, Page 318, https://doi.org/10.1093/ageing/14.5.318-b Published: 01 September 1985

Release from pain: The control of pain in terminal malignant disease

Release from pain: The control of pain in terminal malignant disease

Methodichlorophen as anti-tumor drug.

Methodichlorophen was given to 26 patients with terminal malignant disease. Eight patients received adequate doses, and five of them showed objective evidence of tumour regression while three failed to respond. Those who responded included four out of five patients with lung cancer (three with squamous-cell carcinoma and one with oat-cell carcinoma) and a patient with hypernephroma. Two patients with testicular teratomas and one with acute myeloid leukemia failed to respond. The drug may be given safely by mouth to outpatients if certain precautions are taken.

Modifications of frontal leukotomy for relief of pain and suffering in terminal malignant disease.

Modifications of frontal leukotomy for relief of pain and suffering in terminal malignant disease.